Przemysław Puz

9PUBLICATIONS
12CO-AUTHORS
Innate immunityRheumatology and arthritisPredictive and prognostic markersNeurology and neuromuscular diseasesRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 26, 2026
Longitudinal Changes in Neutrophil-to-Lymphocyte and Monocyte-to-Lymphocyte Ratios During Multiple Sclerosis Relapse.

|Apr 14, 2026
Twenty-Four-Month Real-World Outcomes of Ofatumumab in Relapsing-Remitting Multiple Sclerosis: A Multicenter Retrospective Cohort Study.

Weronika Galus, Magdalena Kiełbowicz-Hołysz, Joanna Siuda

|Mar 28, 2026
Early Prognostic Factors in Multiple Sclerosis: Clinical and Therapeutic Implications.

Katarzyna Maciejowska-Szydło, Przemysław Puz

|Dec 24, 2025
Selected Serum Biomarkers in Patients with Relapsing-Remitting Multiple Sclerosis-A 3-Year Prospective Pilot Study.

Przemyslaw Puz, Katarzyna Maciejowska, Daria Gendosz de Carrillo

|Dec 17, 2025
Did COVID-19 Pandemic Change the Course of Multiple Sclerosis? A Retrospective Eight-Year Study.

Przemyslaw Puz, Marta Konieczna, Katarzyna Maciejowska

|Sep 27, 2025
Real-World Data of First 12-Months of Ofatumumab Treatment in Multiple Sclerosis Patients-A Multicenter Experience from Tertiary Referral Centers.

Weronika Galus, Aleksandra Kaczmarczyk, Anna Walawska-Hrycek

Pageof 2

Frequent Collaborators

6 joint publications

Anetta Lasek-Bal

3 joint publications

Sebastian Student

2 joint publications

Weronika Galus

2 joint publications

Joanna Siuda